Audit of reflux oesophagitis at 4 years

Italian Journal of Gastroenterology and Hepatology

Volumn 30, Issue 4, 1998, Pages 355-360

  Pace, F ^a   Bollani, S ^a   Manzionna, G ^a   Bianchi Porro, G ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Cisapride; Histamine 2 receptor antagonists; Maintenance treatment; Proton pump inhibitors; Reflux oesophagitis

Indexed keywords

CISAPRIDE; HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR;

ADULT; AGED; ANTIREFLUX OPERATION; ARTICLE; BODY POSTURE; DIETARY INTAKE; FEMALE; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; HUMAN; INTERVIEW; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; PATIENT COMPLIANCE; PATIENT SATISFACTION; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRE; RECURRENT DISEASE; REFLUX ESOPHAGITIS; RELAPSE; SYMPTOM; TELEPHONE;

ADULT; AGED; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; DISEASE PROGRESSION; ESOPHAGITIS, PEPTIC; FEMALE; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PROSPECTIVE STUDIES; PROTON PUMPS; QUALITY OF LIFE; QUESTIONNAIRES; RECURRENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0031692173     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Tauris P. Upper gastrointestinal fiberoptic panendoscopy. Endoscopy 1978;10:231-19.
2. Baldi F, Ferrarini F, Morselli Labate AM, Barbara L. Prevalence of esophagitis in patients undergoing upper endoscopy: a multicenter survey in Italy. In: DeMeester T, Skinner DB, (editors) Esophageal disorders: pathophysiology and therapy. New York: Raven Press, 1985:213-9.
3. Ainley CC, Forgacs 1C, Keeling PWN. Outpatients survey of smoking and peptic ulcer. Gut 1986:27:648-52.
4. Stoker DL, Williams JG, Leicester RG, Colin-Jones DG. Oesophagitis: a five years review. Gut 1988;29:A1450.
5. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. J Amer MedAssoc 1991;265:1287-9.
6. Lieberman DA. Medical therapy for chronic reflux esophagitis. Long-term follow up. Ann Intern Med 1987:147:1717-20.
7. Küster E, Ros E, Toledo-Pimentel V, Pujol A, Bordas JM, Grande L, et al. Predictive factors of long-term outcome in gastro-oesophageal reflux disease: six years follow-up of 107 patients. Gut 1994;35:8-14.
8. McDougall NI, Johnston BT, Kee F, Collins JSA, McFarland RJ, Love AHG. Natural history of reflux oesophagitis: a 10 year follow up of its effect on patient symptomatology and quality of life. Gut 1996;38:481-6.
9. Schindlbeck NE, Klauser AG, Berghammer G, Londong W, Mueller-Lissner SA. Three years follow up of patients with gastroesophageal reflux disease. Gut 1992:33:1016-9.
10. Ollyo J-B, Monnier P, Fontolliet C, Savary M. The natural history, prevalence and incidence of reflux oesophagitis. Gullet 1993;3 (Suppl):3-10.
11. Behar J, Sheahan DO, Biancani P, Spiro HM, Storer EH. Medical and surgical management of reflux esophagitis: a 38-month report on a prospective clinical trial. N Engl J Med 1975:293:263-8.
12. Johansson KE, Tibbling L. Maintenance treatment with ranitidine compared with fundoplication in gastro-oesophageal reflux disease. Scand J Gastroenterol 1986:21:779-88.
13. Spechler SJ. Epidemiology and natural history of gastro-oesophageal reflux disease. Digestion 1992;51(Suppl l):24-9.
14. Vigneri S, Termini R, Leandro G, Badalamenti S, Pantalena M, Savarino V, et al. A comparison of five maintenance therapies for reflux esophagitis. N Engl J Med 1995;333:1106-10.
15. Luostarinen M, Isolauri J, Laitinen J, Koskinen M, Keyrilainen O, et al. Fate of Nissen fundoplication after 20 years. A clinical, endoscopical, and functional analysis. Gut 1993;34:1015-20.
16. Blomquist A, Lonroth H, Dalenbaeck J, Ruth M, Wiklund I, Lundell L. Quality of life assessment after laparoscopic and open fundoplications. Results of a prospective, clinical study. Scand J Gastroenterol 1996:31:1052-8.
17. Van Den Boom G, Go PMMYH, Hameeteman W, Dallemagne B. Cost effectiveness of medical versus surgical treatment in patients with severe or refractory gastroesophageal reflux disease in The Netherlands. Scand J Gastroenterol 1996:31:1-9.
18. Heudebert GR, Marks R, Wilcox MC, Center RM, Choice of long-term strategy for the management of patients with severe esophagitis: a cost utility analysis. Gastroenterology 1997;112:1078-86.
19. Howden CW, Castell DO, Cohen S, Freston JW, Orlando RC, Robinson M. The rationale for continuous maintenance treatment of reflux esophagitis. Arch Intern Med 1995:155:1465-71.